Phosphorylation state and protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (immunofluorescence dataset 4 of 4) - Dataset (ID:20277)

Filter results: >>>>
  • Page 1 of 29
  • 1 to 25 of 720 records
Cell Small Molecule 1 Small Molecule 2 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Primary Antibody (488) Secondary Antibody (488) Protein Detected (488) Mean Fluorescence Intensity (488) Primary Antibody (647) Secondary Antibody (647) Protein 1 Detected (647) Protein 2 Detected (647) Protein 3 Detected (647) Protein 4 Detected (647) Mean Fluorescence Intensity (647) Plate Name Plate Well
A-375 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 -27.79 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 335.52
A375-P4
B10
COLO 858 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 158.06 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 622.29
Colo858-P2
B10
WM-115 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 19.02 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) -3.07
WM115-P1
B10
COLO 858 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 192.32 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 28.22
Colo858-P1
B10
A-375 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 87.44 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 16.69
A375-P1
B10
COLO 858 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 150.23 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 188.77
Colo858-P4
B10
WM-115 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 -1.15 NGFR rabbit IgG(H+L) / donkey NGFR 2136.86
WM115-P3
B10
COLO 858 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 173.30 NGFR rabbit IgG(H+L) / donkey NGFR 320.04
Colo858-P3
B10
WM-115 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 20.26 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 189.45
WM115-P2
B10
A-375 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 5.54 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 788.73
A375-P2
B10
WM-115 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 14.28 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 391.41
WM115-P4
B10
A-375 Vemurafenib Trametinib 1.000 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 21.32 NGFR rabbit IgG(H+L) / donkey NGFR 582.87
A375-P3
B10
A-375 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 -50.96 NGFR rabbit IgG(H+L) / donkey NGFR 377.54
A375-P3
B11
WM-115 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 -39.46 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 280.80
WM115-P4
B11
WM-115 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 -40.12 NGFR rabbit IgG(H+L) / donkey NGFR 1602.91
WM115-P3
B11
WM-115 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 0.47 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 0.07
WM115-P1
B11
COLO 858 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 160.24 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 352.27
Colo858-P2
B11
A-375 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 -102.60 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 307.17
A375-P4
B11
COLO 858 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 208.84 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 27.54
Colo858-P1
B11
COLO 858 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 102.66 NGFR rabbit IgG(H+L) / donkey NGFR 69.04
Colo858-P3
B11
A-375 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 39.13 ERK-1 (pT202; pY204); ERK-1 (pT202); ERK-2 (pT185; pY187); ERK-2 (pT185) rabbit IgG(H+L) / donkey ERK-1 (pT202; pY204) ERK-1 (pT202) ERK-2 (pT185; pY187) ERK-2 (pT185) 9.87
A375-P1
B11
A-375 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 -53.15 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 663.30
A375-P2
B11
COLO 858 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 2.87 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 25.49
Colo858-P4
B11
WM-115 Vemurafenib Trametinib 3.160 0.200
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 -39.94 c-Jun / clone 60A8 rabbit IgG(H+L) / donkey c-Jun 172.43
WM115-P2
B11
COLO 858 Vemurafenib 0.000
uM
48
hr
1 KI-67 / clone 8D5 mouse IgG(H+L) / donkey KI-67 1380.77 S6 (pS240; pS244) rabbit IgG(H+L) / donkey S6 (pS240; pS244) 2910.42
Colo858-P4
B2
  • Page 1 of 29
  • 1 to 25 of 720 records